Canada · Delayed Price · Currency is CAD AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of CAD 524.77 billion. The enterprise value is 611.23 billion.
| Market Cap | 524.77B |
| Enterprise Value | 611.23B |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Jan 16, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.00% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 73.67% |
| Float | 1.76B |
Valuation Ratios
The trailing PE ratio is 90.57 and the forward PE ratio is 14.79.
| PE Ratio | 90.57 |
| Forward PE | 14.79 |
| PS Ratio | 6.26 |
| PB Ratio | -147.26 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 105.49 |
| EV / Sales | 7.31 |
| EV / EBITDA | 15.80 |
| EV / EBIT | 22.25 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.43 |
| Debt / FCF | n/a |
| Interest Coverage | 7.65 |
Financial Efficiency
Return on equity (ROE) is 1,106.67% and return on invested capital (ROIC) is 21.28%.
| Return on Equity (ROE) | 1,106.67% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 21.28% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.52M |
| Profits Per Employee | 105,352 |
| Employee Count | 55,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AbbVie has paid 3.24 billion in taxes.
| Income Tax | 3.24B |
| Effective Tax Rate | 35.83% |
Stock Price Statistics
The stock price has increased by +11.20% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +11.20% |
| 50-Day Moving Average | 31.64 |
| 200-Day Moving Average | 29.59 |
| Relative Strength Index (RSI) | 44.38 |
| Average Volume (20 Days) | 11,750 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AbbVie had revenue of CAD 83.86 billion and earned 5.79 billion in profits. Earnings per share was 3.24.
| Revenue | 83.86B |
| Gross Profit | 58.90B |
| Operating Income | 27.55B |
| Pretax Income | 9.05B |
| Net Income | 5.79B |
| EBITDA | 38.79B |
| EBIT | 27.55B |
| Earnings Per Share (EPS) | 3.24 |
Balance Sheet
The company has 7.78 billion in cash and 94.40 billion in debt, with a net cash position of -86.62 billion.
| Cash & Cash Equivalents | 7.78B |
| Total Debt | 94.40B |
| Net Cash | -86.62B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -3.56B |
| Book Value Per Share | -2.05 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.24%, with operating and profit margins of 32.85% and 6.91%.
| Gross Margin | 70.24% |
| Operating Margin | 32.85% |
| Pretax Margin | 10.79% |
| Profit Margin | 6.91% |
| EBITDA Margin | 46.26% |
| EBIT Margin | 32.85% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.95, which amounts to a dividend yield of 3.09%.
| Dividend Per Share | 0.95 |
| Dividend Yield | 3.09% |
| Dividend Growth (YoY) | 3.60% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -1.00% |
| Shareholder Yield | 2.09% |
| Earnings Yield | 1.10% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |